000 01494 a2200385 4500
005 20250511195703.0
264 0 _c19911029
008 199110s 0 0 eng d
022 _a0008-543X
024 7 _a10.1002/1097-0142(19911015)68:8<1703::aid-cncr2820680809>3.0.co;2-k
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aThomas, P R
245 0 0 _aResults of two radiation therapy randomizations in the third National Wilms' Tumor Study.
_h[electronic resource]
260 _bCancer
_cOct 1991
300 _a1703-7 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCombined Modality Therapy
650 0 4 _aDactinomycin
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aKidney Neoplasms
_xpathology
650 0 4 _aNeoplasm Recurrence, Local
650 0 4 _aNeoplasm Staging
650 0 4 _aRadiotherapy Dosage
650 0 4 _aVincristine
_xadministration & dosage
650 0 4 _aWilms Tumor
_xpathology
700 1 _aTefft, M
700 1 _aCompaan, P J
700 1 _aNorkool, P
700 1 _aBreslow, N E
700 1 _aD'Angio, G J
773 0 _tCancer
_gvol. 68
_gno. 8
_gp. 1703-7
856 4 0 _uhttps://doi.org/10.1002/1097-0142(19911015)68:8<1703::aid-cncr2820680809>3.0.co;2-k
_zAvailable from publisher's website
999 _c1661701
_d1661701